Home » FDA Extends Comment Period for Special Protocol Guidance
FDA Extends Comment Period for Special Protocol Guidance
The FDA has extended its comment period for a draft guidance on special protocol assessments for investigational new drugs to July 19.
The agency attributes the extension to maintenance on the Federal eRulemaking portal from July 1 through July 5.
The draft guidance was previously released for comment in May.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May